This clinical trial is focused on the prevention of female infertility. The study is investigating a method called Random Start Ovarian Stimulation to see how it compares to the traditional method of stimulating the ovaries during the early part of the menstrual cycle. The goal is to determine which method is more effective in preserving eggs for future use. This process is known as Elective Oocyte Cryopreservation, which involves freezing eggs to potentially use them later for pregnancy.
Participants in the study will receive one of the following treatments: Bemfola, which contains the active substance follitropin alfa and is given as an injection under the skin; Duphaston, which contains dydrogesterone and is taken as a tablet by mouth; or Gonapeptyl Daily, which contains triptorelin acetate and is also given as an injection under the skin. Some participants may receive a placebo. The study will last for a period of up to 21 days, during which the effectiveness of these treatments in stimulating the ovaries will be assessed.
The purpose of this study is to find out if the new method of ovarian stimulation is as effective as the traditional method in producing mature eggs that can be frozen. Participants will be monitored throughout the study to track the number of eggs retrieved and the amount of medication used. The study aims to provide valuable information that could help improve fertility preservation techniques for women in the future.
Belgium 
